Survey of Ophthalmology
Volume 47, Issue 1 , Pages 68-73, January 2002

II. Choosing Beta-Blockers for Initial Medical Therapy For Glaucoma☆

  • Stephen A Wigginton, MD
    • ,
  • Eve J Higginbotham, MD

      Affiliations

    • Corresponding Author InformationReprint address: Eve J. Higginbotham, MD, Department of Ophthalmology, University of Maryland School of Medicine, 419 W. Redwood Street Suite 580, Baltimore, MD 21201

Department of Ophthalmology, University of Maryland School of Medicine, Baltimore, MD, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ The authors have no commercial or proprietary interest in any product or concept discussed in this article. Supported in part by a grant from Research to Prevent Blindness, New York, NY.

PII: S0039-6257(01)00287-9

Survey of Ophthalmology
Volume 47, Issue 1 , Pages 68-73, January 2002

Article Tools